After Hours Summary: COST -0.7% modestly lower on earnings; CNXC -21.6%, LGCY -12.9%, LPTH -6.9% lower on earnings; CRNX halted, but FDA approves PALSONIFY for acromegaly
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: FTI +2.1% (awarded a substantial contract by ExxonMobil Guyana), TXT +2% (awarded a $163 mln Army contract; also awarded a $359 mln modification to DLA contract), ORCL +1.4% (President Trump signs exec order approving TikTok deal, according to CNBC), GOOG +1% (META discussing with Google on using Gemini to boost ad targeting, according to The Information), SAP +1% (awarded a $1 bln US Army contract for an end user license agreement), ZBH +0.9% (Japan PMDA approval of hip replacement system), PSEC +0.7% (CEO bought 384000 worth ~$1.02 mln), HROW +0.6% (launches Harrow Access for All), EXK +0.6% (intersects high-grade silver-lead-zinc mineralization at its Kolpa Operation), LMT +0.5% (awarded a $610 mln modification to previously awarded Navy contract), BA +0.3% (awarded a $671 mln Defense Logistics Agency contract), CDTX +0.2% (first participants dosed in Phase 3 ANCHOR trial), MTUS +0.1% (co and union extend contract)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CNXC -21.6% (also increases dividend), LGCY -12.9%, LPTH -6.9%, COST -0.7%
Companies trading lower in after hours in reaction to news: ORGO -12% (provides update on Second Phase 3 ReNu study), NFGC -2.1% (confirms at-surface high-grade core), NN -0.6% (stock offering by selling shareholders), GVA -0.6% (wins $39 mln US Army Corps of Engineers contract), SBET -0.4% (increases share buyback authorization), MRCY -0.2% (receives $12.3 mln contract from a defense prime contractor), KURA -0.1% (publication of pivotal Ziftomenib data), CRNX -0.1% (FDA approves PALSONIFY for acromegaly)